[Specific immunotherapy of prostate carcinoma].
For the first time since the introduction of female sex hormone treatment of carcinoma of the prostate, an entirely new therapeutic approach was tried, i.e., specific immune therapy in the form of chessboard vaccination. With this method, and continuation of hormone therapy, inactivated cancerous cells were injected with neuraminidase intracutaneously into the thigh. Should hormone therapy prove ineffective, a long-term therapeutic effect can be achieved in approximately half of the patients by giving three vaccinations containing 44,400,000 cells. The effectiveness of specific immunotherapy in the form of chessboard vaccinations could be established on the basis of a significant drop in serum phosphatases and carcinoembryonic antigen under therapy, the scintigraphic evidence of remission of osteometastases and not least of all a statistically significant increase in the survival rate during treatment of unconfined metastasizing prostate carcinomas. Even in early stages specific immunotherapy constitutes a new alternative therapeutic method, particularly in the treatment of hormone-independent prostate carcinomas and in cases of estrogen intolerance.
D002277:Carcinoma / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy*; D014613:Vaccines, Attenuated
D014613:Vaccines, Attenuated
Die spezifische Immuntherapie des Prostatakarzinoms.